Age-Related Clonal Hematopoiesis as a Driver of Breast Cancer Awakening and Metastatic Relapse IN PARTNERSHIP WITH THE SAMUEL WAXMAN CANCER RESEARCH FOUNDATION (2023-PRESENT) Julio Aguirre-Ghiso, PhD, Albert Einstein College of Medicine; Ross Levine, MD, Memorial Sloan Kettering Cancer Center Read More
Epigenetic and Metabolic Vulnerabilities in High-Risk Pediatric Acute Myeloid Leukemia IN PARTNERSHIP WITH GABRIELLE'S ANGEL FOUNDATION FOR CANCER RESEARCH (2023-PRESENT) Jeffrey Magee, MD, PhD, Grant Challen, PhD, Stephen Sykes, PhD, Washington University in St. Louis Read More
Chromatin Remodeling INO80 Complex as Targeted Therapeutics Platform in Hematologic Malignancies IN PARTNERSHIP WITH GABRIELLE'S ANGEL FOUNDATION FOR CANCER RESEARCH (2023-PRESENT) David Dominguez-Sola, MD, PhD, Icahn School of Medicine at Mount Sinai-Tisch Cancer Institute; Daniel Herranz-Benito, PharmD, PhD, Rutgers Cancer Institute of New Jersey Read More
Mechanisms of Cellular Response to Errors in Mitosis: a New, non-Genetic Approach to an Old Question IN PARTNERSHIP WITH THE EUROPEAN ASSOCIATION FOR CANCER RESEARCH AND THE PEZCOLLER FOUNDATION (2024-PRESENT) Stamatis Papathanasiou, PhD, The Institute of Molecular Biology Read More
Tumor Promotion and Protection ASPIRE II Award, (2023-Present) Charles Swanton, FRCP, BSc, PhD, The Francis Crick Institute (United Kingdom); Sherene Loi, MD, PhD, Division of Cancer Research, The Sir Peter MacCallum Department of Oncology/University of Melbourne (Australia) Read More
Personalized T Cell-Directed Cancer Immunotherapy 2023 Endeavor Award Dana-Farber Cancer Institute: Catherine Wu, MD • The Broad Institute: Nir Hacohen, PhD; Fei Chen, PhD Read More
